{
    "id": 13139,
    "fullName": "PAX8 - PPARG",
    "impact": "fusion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "PAX8-PPARG results from the fusion of PAX8 and PPARG, demonstrating transforming ability in culture through inhibition of native Pparg activity (PMID: 15077183).",
            "references": [
                {
                    "id": 3765,
                    "pubMedId": 15077183,
                    "title": "The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15077183"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7849,
        "geneSymbol": "PAX8",
        "terms": [
            "PAX8"
        ]
    },
    "variant": "PAX8 - PPARG",
    "createDate": "10/15/2015",
    "updateDate": "02/27/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 5468,
                "geneSymbol": "PPARG",
                "terms": [
                    "PPARG",
                    "CIMT1",
                    "GLM1",
                    "NR1C3",
                    "PPARG1",
                    "PPARG2",
                    "PPARgamma"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 7235,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Actos (pioglitazone) treatment reduced thyroid size, normalized thyroid function, and inhibited local invasion in mouse thyroid cancer models expressing PAX8 - PPARG and were null for PTEN (PMID: 25069464).",
            "molecularProfile": {
                "id": 24799,
                "profileName": "PAX8 - PPARG PTEN del"
            },
            "therapy": {
                "id": 3125,
                "therapyName": "Pioglitazone",
                "synonyms": null
            },
            "indication": {
                "id": 1781,
                "name": "thyroid gland cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4045,
                    "pubMedId": 25069464,
                    "title": "Pax-8-PPAR-\u03b3 fusion protein in thyroid carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25069464"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13304,
            "profileName": "PAX8 - PPARG",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24799,
            "profileName": "PAX8 - PPARG PTEN del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}